Review of cancer-associated fibroblasts and their microenvironment in post-chemotherapy recurrence
- PMID: 32852669
- DOI: 10.1007/s13577-020-00417-8
Review of cancer-associated fibroblasts and their microenvironment in post-chemotherapy recurrence
Abstract
Cancer tissue comprises not only cancer cells, but also several types of non-cancerous cells, such as cancer-associated fibroblasts. These fibroblasts directly and/or indirectly communicate with the cancer cells and other types of stromal cells, to create a specific tumor microenvironment. Cytotoxic chemotherapy plays a central role in treating cancer; however, tumor re-progression (recurrence) is a significant problem for cancer patients. Cytotoxic anticancer drugs act on fibroblasts as well as cancer cells and, after chemotherapy, all surviving cells are in contact with one another in the local environment. Therefore, an understanding of the molecular interactions between surviving cancer cells and fibroblasts is necessary to prevent tumor re-progression and to sustain the effect of cytotoxic agents. After chemotherapy, the number of fibroblasts may increase, some of which are identifiable as tumor-promoting. In this review, we discuss the significance of cancer-associated fibroblasts in tumor re-progression after chemotherapy, and the potential value of targeting them to enhance clinical outcomes.
Keywords: Cancer-associated fibroblasts; Post chemotherapy; Tumor microenvironment; Tumor re-progression.
Similar articles
-
Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.OMICS. 2020 Apr;24(4):175-179. doi: 10.1089/omi.2020.0019. Epub 2020 Mar 13. OMICS. 2020. PMID: 32176591 Review.
-
Diversity and Biology of Cancer-Associated Fibroblasts.Physiol Rev. 2021 Jan 1;101(1):147-176. doi: 10.1152/physrev.00048.2019. Epub 2020 May 28. Physiol Rev. 2021. PMID: 32466724 Free PMC article. Review.
-
Strategies of targeting pathological stroma for enhanced antitumor therapies.Pharmacol Res. 2019 Oct;148:104401. doi: 10.1016/j.phrs.2019.104401. Epub 2019 Aug 15. Pharmacol Res. 2019. PMID: 31422113 Review.
-
Reflections on depletion of tumor stroma in pancreatic cancer.Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):267-272. doi: 10.1016/j.bbcan.2019.01.007. Epub 2019 Feb 6. Biochim Biophys Acta Rev Cancer. 2019. PMID: 30738097 Review.
-
Core-shell nanoparticles suppress metastasis and modify the tumour-supportive activity of cancer-associated fibroblasts.J Nanobiotechnology. 2020 Jan 21;18(1):18. doi: 10.1186/s12951-020-0576-x. J Nanobiotechnology. 2020. PMID: 31964403 Free PMC article.
Cited by
-
Spatiotemporal heterogeneity of LMOD1 expression summarizes two modes of cell communication in colorectal cancer.J Transl Med. 2024 Jun 7;22(1):549. doi: 10.1186/s12967-024-05369-3. J Transl Med. 2024. PMID: 38849852 Free PMC article.
-
Loss of tumor suppressor menin expression in high grade cholangiocarcinomas.BMC Res Notes. 2023 Feb 13;16(1):15. doi: 10.1186/s13104-023-06282-6. BMC Res Notes. 2023. PMID: 36782257 Free PMC article.
-
The role of cancer-associated fibroblasts in the tumour microenvironment of urinary system.Clin Transl Med. 2025 Apr;15(4):e70299. doi: 10.1002/ctm2.70299. Clin Transl Med. 2025. PMID: 40195290 Free PMC article. Review.
-
Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma.Front Oncol. 2023 Apr 14;13:1170893. doi: 10.3389/fonc.2023.1170893. eCollection 2023. Front Oncol. 2023. PMID: 37124542 Free PMC article.
-
Reassessing Breast Cancer-Associated Fibroblasts (CAFs) Interactions with Other Stromal Components and Clinico-Pathologic Parameters by Using Immunohistochemistry and Digital Image Analysis (DIA).Cancers (Basel). 2023 Jul 27;15(15):3823. doi: 10.3390/cancers15153823. Cancers (Basel). 2023. PMID: 37568639 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical